Effects of serial resin hemoperfusion in fulminant hepatic failure.
Resin hemoperfusion using an albumin coated Amberlite XAD-7 column was performed in 19 patients in coma due to fulminant hepatic failure. The procedure was clinically well tolerated, with good blood compatibility, platelet and white cell levels being 97.3 +/- SE 3.2% and 105 +/- 3.8% of the respective initial values after four hours hemoperfusion. No significant changes were observed in beta-thromboglobulin, screen filtration pressure, plasma electrolytes, calcium, protein or albumin. The total plasma bilirubin fell by a mean of 24 mumol/l, with a reduction in 21 of the 25 perfusions studied of up to 104 mumol/l during perfusion. Mean plasma levels of total bile acids were 137 +/- 19 mumol/l and 115 +/- 16 mumol/l respectively before and after four hours hemoperfusion. The amount of bile acids recovered by elution of the resin column was over three times greater than that apparent from the change in plasma levels. Column chromatography on Sephadex G-25 of material eluted from the resin column showed various peaks to be removed, including substances in the middle molecular weight range (1000-5000 daltons). Of the patients treated, eight (42%) survived to leave hospital.
D000180:Acrylic Resins; D000293:Adolescent; D000328:Adult; D001647:Bile Acids and Salts / Q000097:blood; D001663:Bilirubin / Q000097:blood; D005260:Female; D006464:Hemoperfusion; D006501:Hepatic Encephalopathy / Q000628:therapy; D006801:Humans; D008107:Liver Diseases / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011137:Polystyrenes
D000180:Acrylic Resins; D001647:Bile Acids and Salts; D011137:Polystyrenes; C015661:amberlite XAD 7; D001663:Bilirubin